NC
Nirav Chandulal Bhalani
About Nirav Chandulal Bhalani
Data last updated:
Nirav Chandulal Bhalani is a Director at Synergy Lifecare Private Limited (since 2012) and Director at Nuvaryas Healthcare Private Limited (since 2025). The companies operate in Healthcare. The largest current company by reported revenue is Synergy Lifecare Private Limited at ₹85.64 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Synergy Lifecare Private Limited U85110GJ2012PTC073154 | Director | 28 Dec 2012 | 2012 | ₹85.64 Cr (FY 2025) | Active |
| Nuvaryas Healthcare Private Limited U86100GJ2025PTC164380 | Director | 21 Jun 2025 | 2025 | Active |
Board colleagues of Nirav Chandulal Bhalani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arvindkumar Omprakash Sharma | 06457334 | Synergy Lifecare Private Limited , Nuvaryas Healthcare Private Limited | Director |
| Chirag Vipinchandra Sheth | 06457341 | Synergy Lifecare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nirav Chandulal Bhalani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirav Chandulal Bhalani
Nirav Chandulal Bhalani currently holds 2 directorships: Synergy Lifecare Private Limited (Director, since 28 Dec 2012, revenue ₹85.64 Cr (FY 2025)); Nuvaryas Healthcare Private Limited (Director, since 21 Jun 2025).
Nirav Chandulal Bhalani was first appointed on 28 Dec 2012 as Director at Synergy Lifecare Private Limited. The most recent appointment on record is 21 Jun 2025 at Nuvaryas Healthcare Private Limited.
The current boards of Nirav Chandulal Bhalani's companies include Arvindkumar Omprakash Sharma (Synergy Lifecare Private Limited), Chirag Vipinchandra Sheth (Synergy Lifecare Private Limited).